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Tuberculosis (TB) in children, particularly in those under five years is regarded as an indicator of 
there being an infectious pool in the community. The World Health Organization (WHO) has 
focused on childhood tuberculosis, recognizing its contribution to the overall TB burden and to 
child survival. The Roadmap for Childhood Tuberculosis identifies the need to know the 
incidence of childhood TB in order to design and implement specific public health interventions 
to limit the spread of the disease and orientate health services in early TB detection, treatment 
and retention in care to prevent on-going transmission. 
Aim  
The aim of this research is to investigate the epidemiology of childhood TB in South Africa (SA) 
from 2008 to 2012 in order to inform TB control policy and practice. 
Methods 
An observational analytical cross sectional study design was used. The Electronic TB Register 
was used as the source of the data. Records from 1 January 2008 to 31 December 2012 were 
used. STATA and Excel were used to describe and analyse data. 
Results 
The proportion of children aged 0 to 14 years with TB in SA has fluctuated between 19.2% in 
2008, reaching a high of 22.3% in 2009 and reducing to 18.8% in 2012. Testing children with 
TB for HIV has increased steadily from 17.9% in 2008 to 68.5% in 2012. The HIV prevalence in 
tested cases aged ten to fourteen years in 2012 was the highest at 42.6% with the lowest 
prevalence found in the zero to four year age group in 2012 of 16.7%. In analysing treatment 
outcomes, the children aged five to nine years had 21% (0.79) less risk of death compared to the 





The WHO expects the proportion of childhood TB in high burden countries to be between ten 
and twenty percent. In SA the proportion of childhood TB has been above this level in 2009, it 
now falls within the upper limit of this expectation and has decreased annually since 2010. Given 
the large tuberculosis infectious pool in the country this is to be expected. Some progress is 
being made towards achieving the goal of HIV screening for all children with TB with the 
highest proportion tested being the age group ten to fourteen years.  
Conclusion and Recommendations    
Capacity building of clinicians in effective early TB case finding, appropriate management and 
better data recording and monitoring in children using the TB register is essential. Regular 
feedback of progress against programmatic targets would assist in focusing interventions to 
improve service delivery in TB in children. Youth friendly interventions for children that focus 
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1. CHAPTER I: INTRODUCTION 
1.1 BACKGROUND 
The World Health Organization (WHO) declared tuberculosis (TB) a global emergency 
in 1993, with South Africa (SA) being one of 22 high burden countries. 
1 
In 2012, South 
Africa had a TB incidence of 1003 per 100 000 population placing it amongst the highest 
in the world. 
2 
Tuberculosis has increasingly been recognised as a major cause of 
morbidity and mortality among children in high TB burden settings. 
3,4,5 
In a viewpoint 
article published in the Lancet in 2014, the importance of TB control in addressing child 
survival was highlighted, relating this to Millennium Developmental Goal 5. 
5 
The 
Roadmap for Childhood Tuberculosis calls for strengthened reporting of TB cases 
occurring in children by national TB programmes, and among its ten key actions are 
inclusion of the needs of children and adolescents in research; policy development and 
clinical practice; and, collection and reporting of better data, including data on TB 
preventive measures directed at children. 
4
 
Although the South African Children’s Act 38 of 2005 defines a child as being less than 
18 years of age, WHO defines childhood TB as the form of the disease that affects those 
under the age of 15 years. 
6, 7 
Few countries report childhood TB incidence, as data is 
seldom available. The diagnosis of TB in children is difficult, usually based on history 
and clinical findings, and rarely supported by laboratory confirmation. 
6,9,10,11 
In a best 
practice article in the Postgraduate Medical Journal, Hoskyns discusses the importance of 
childhood TB as a marker of recent TB transmission and a possible source of future TB 
disease. Children who have had TB are more likely to contract TB disease later in life. 
12
 
In this study, we used data from all children reported with TB on the Electronic 
Tuberculosis Register (ETR.Net) in SA from 1 January 2008 to 31 December 2012. The 
purpose of the study was to describe the epidemiology of childhood TB in South Africa 




The findings of this study can assist the Department of Health to determine if the 
national picture of childhood TB is similar to that found by Marais et al. in 2004, and to 
implement targeted child-appropriate TB interventions designed with a focus on 
prevention, early detection, treatment as well as improved recording in order to 
effectively manage the programme and decrease the burden of TB in children. 
1.2 SPECIFIC OBJECTIVES 
The specific objectives of this research are: 
a. to describe TB incidence trends by age, sex and other demographic variables; 
b. to compare the proportion of childhood TB cases in South Africa to the WHO 
estimated proportions for childhood TB cases in high burden countries; and 
c. to determine if there are any associations between demographic variables and 
clinical outcomes of childhood TB. 
1.3 DEFINITIONS 
Electronic TB Register (ETR.Net) 
The ETR.Net is an electronic TB register used in South Africa, designed for TB 
surveillance, programme monitoring and evaluation. 
Childhood TB 
Children under 15 years of age diagnosed with TB by means of bacteriological, 
radiological or clinical findings. 
TB Outcomes 
The health outcome of the patient at the end of the treatment as defined by the 
National Tuberculosis Management Guidelines 2014: 
Cure: Patient who is smear-negative in the last month of treatment and on at 
least one previous occasion at least 30 days prior. 
3 
 
Treatment completed: Patient who has completed treatment but who does not 
meet the criteria to be classified as being cured or having failed treatment. 
Treatment success: Patient who is cured or has completed treatment. 
Treatment failure: Smear positive patient who remains or is again smear- 
positive at five months (for new) or seven months (for retreatment) after 
treatment start date or whose drug susceptibility test (DST) shows drug resistant 
TB (DR-TB) at two or three months. 
Died: Patient who dies for any reason during the course of TB treatment.a 
Treatment default: Patient whose treatment was interrupted for more than two 
consecutive months. 
Transfer out: Patient who has been transferred to another reporting unit (e.g. 
district) and for whom the treatment outcome is not known 
13 
Cumulative TB Incidence in Children 
The proportion of children under 15 years who developed active TB disease during 
the specified time period, reported for the age groups 0 to 4, 5 to 9 and 10 to 14 
years against the district, provincial and national estimated populations for those age 
groups according to the 2011 census report produced by Statistics South Africa. 
13
 
Childhood TB Prevalence 
The total number of children with TB disease currently on treatment. 
Drug Resistant TB 
TB caused by strains of Mycobacterium tuberculosis that are resistant to isoniazid 
and/or rifampicin or any other first line drug. 
                                            
a The WHO defines TB deaths as all-cause mortality before completing anti-tuberculosis treatment 
4 
 
SUMMARY OF CHAPTER 
Tuberculosis in children is accepted as an indicator of the burden of TB disease and the 
pool of TB infection in the community. Knowledge and understanding of the 
epidemiology of childhood TB will assist health service managers to plan efficiently to 
reduce the morbidity and mortality of children infected with TB. This chapter outlines 




2 CHAPTER II: LITERATURE REVIEW 
2.1 INTRODUCTION 
The focus on childhood TB has gained momentum in recent years. There is greater 
awareness that the increased incidence of childhood TB in a community is a reflection of 
the bigger burden of TB in adults in the same community. There is little recent literature 
available on the epidemiology of TB in children in South Africa, and studies available, 
other than a small study in the Western Cape, are based mostly in Europe and North 
America where the burden of TB is very low. 
2.2 PURPOSE OF THE LITERATURE REVIEW 
The purpose of this literature review was to look for similar countrywide studies on the 
demographic profiles and outcomes for childhood TB. Studies and other literature 
regarding TB in children globally, regionally and from South Africa were reviewed. 
There are very few recent studies on the epidemiology of childhood TB, the most recent 
South African study was done by the Desmond Tutu TB Centre in 2004 in 2 
communities in the Western Cape. 
14 
The majority of the studies have been specifically 
related to the diagnosis and treatment of childhood TB. 
2.3 SCOPE OF LITERATURE REVIEW 
The literature review is limited to studies on children aged 0 to 14 years. The review 
will describe the available literature on the demographic profile of childhood TB in 
South Africa. The proportion of cases in South Africa will be compared to the WHO 
estimated proportions expected in a high TB burden countries. 
2.4 LITERATURE REVIEWED 
The electronic databases PubMed and Google Scholar were searched for studies on the 
epidemiology of childhood TB. The keywords and phrases, “childhood TB”, 
“epidemiology of childhood TB”, “targeting interventions for TB”, “incidence of 
childhood TB” and “outcomes for childhood TB” were used with or without the 
6 
 
Boolean operators “and” and “or”. Relevant citations in the identified literature were 
also used to search for further information. 
7 
 
2.4.1 Burden of TB 
The WHO Global Taskforce on TB Impact Measurement uses the measures of 
incidence, prevalence and mortality to estimate the burden of TB. For the purposes of 
this study, we will use only incidence and prevalence. Incidence is defined as “the 
number of new and recurrent (relapse) episodes of TB (all forms) occurring in a given 
year”, prevalence as “the number of TB cases (all forms) at a given point in time”. 
According to the WHO, TB remains the second leading cause of death in the world and 
substantially affects the health of millions of people. The Centers for Disease Control 
(CDC) defines TB infection as those persons that have been exposed to the 
mycobacterial bacillus and have become infected as shown by a positive Tuberculin 
Skin Test (TST) but are not ill. TB disease, however applies to those who are infected 
by the M.tb and have become ill and present with symptoms of active TB. 
15
 
Globally, there were 10.4 million people diseased with TB in 2015. Of these 1 million 
were children. 
16 
South Africa was one of 6 countries who together accounted for 60% of 
the global TB burden. 
18 
The African Region accounted for 26% (estimated 2.7 million 
cases) of the global TB burden with an estimated incidence of 275 per 100 000 (95% 
Confidence Interval (CI): 239 to 315) in 2015.  South Africa had an estimated 454 000 
cases (95% CI: 294 000 to 649 000) and an estimated prevalence of 834 per 100 000 (95% 
CI: 539 to 1190) in 2012. 
17 
The prevalence of TB infection is not routinely measured due 
to the resource requirements of conducting large-scale cohort studies, the expense 
involved of performing TST and because where the Bacillus Calmette-Guerin (BCG) 
vaccine is routinely used, most children should have a positive TST. 
In a WHO policy paper, it is stated that a country’s notification system is considered a 
satisfactory proxy indicator for incidence of TB. 
18 
In South Africa notification of TB is 
compulsory and is legislated under the National Health Act 63 of 2003 as amended. 
19 
Due to the vast number of TB cases in South Africa, the Electronic TB Register is felt to 
be a more reliable method than using the Notification of Medical Conditions 
surveillance system used for other notifiable medical conditions. The data from the 
8 
 
ETR.Net system informs South Africa’s TB data reporting to the WHO. It is reported 
that in 2012 there were 530 000 (95% CI: 430 000 to 630 000) new cases of 
9 
 
TB in South Africa. The cumulative incidence of 1000 per 100 000 population (95% CI: 
827 to 1190) is the highest reported from amongst the high burden countries globally. 
17
 
2.4.2 Demographic profile of childhood TB 
Very few studies have been published on demographic profiles of children with TB. A 
prospective observational study conducted over an 18-month period by Marais et al. in a 
high burden community in Cape Town found that children under the age of 13 years 
comprised 14% of the total TB caseload, which is close to the WHO estimate of 15% for 
high burden countries. 
20 
The proportion of children less than 3 years was 54%. The sex 
ratio in these children was equal, 65% of the children had been tested for HIV, and 8.8% 
were HIV positive. 
In 1998, Van Rie et al., in another Cape Town based study reported that childhood TB 
represented 37 to 58% of the total TB caseload. 14 Children aged 0 to 4 years comprised 
25 to 49% of the total childhood TB caseload. A longitudinal study of 93 children with 
TB in Solapur City, India in 2012 by Bandichhode ST et al. 
21 
found that 37% were 
aged 1 to 5 years, 29% 5 to 10 years and 29% were in the 10 to 15 year age group. 
Infants comprised 5% of the childhood TB in this study. These proportions are similar 
to those reported from Cape Town. In addition, the sex distribution was equal. 
In a larger retrospective descriptive study also in India that comprised 541 children with 
TB, from 2000 to 2010, 39 were 13 to 14 years old, which differs from most other 
studies. 
24 
Females comprised 65% of the cases, also differing from other studies. These 
children were not tested for HIV.  Only 3.8% of the children were under 5 years of age. 
2.4.3 World Health Organization estimated proportions for childhood TB 
The WHO estimates that in high burden settings, it is expected that TB in children will 
comprise 10 to 20% of the total TB caseload. 
22 
Globally childhood TB is on the 
increase in many countries although 75% of childhood TB cases notified in 2000 were 
from high TB burden countries. In the same year, (2000) in unpublished National TB 
Programme data, Botswana reported an increased number and proportion (12%) of 
10 
 
children (< 15 years) with TB. 
23 
A study done by Van Rie et al.14
 
in two urban 
communities in Cape Town in 1998 reported that according to TB case notification 
data, childhood TB comprised 45% (95% CI: 37% to 58%) of the total TB burden in  
these communities. 
25 
The number of childhood TB cases aged 0 to 4 years (n=1383) 
comprised 36% of the total TB caseload, while the 5 to 14 year age group had 9% of 
the total reported cases of TB. 
25 
As this study was confined to two peri-urban 
communities in Cape Town the findings cannot be generalised to the whole South 
African population. This study was located in two small communities in the Western 
Cape, which is one of the highest burden areas in South Africa. The results may have 
been affected by sampling bias as this study was not a representative sample of the 
country burden of disease.  
2.4.4 Bacteriological Coverage 
Few countries report indicators of childhood TB incidence, as data is seldom available. 
The absence of a “gold standard” for diagnosis of TB in children 
24,25 
continues to 
complicate diagnosis which is therefore usually based on history and clinical findings, 
and rarely supported by laboratory confirmation. 
6,9,10,11 
Obtaining a suitable sputum 
sample from children as well as the frequency of low bacillary counts found in children, 
makes a bacteriological diagnosis difficult. Obtaining suitable specimens would require 
procedures such as gastric lavage, nebulization, or broncho-alveolar lavage, which all 
require overnight hospitalisation, in a facility with good infection control and suitably 
trained staff. 
26 
No data could be found on bacteriological coverage in children less than 
7 years of age for comparison. Other bacteriological coverage data for children older 
than 7 years is aggregated with adult data and therefore could not be determined. 
The problem of obtaining a firm diagnosis of TB in children is further complicated by 
“the increased presence of extra-pulmonary disease in young children [and] the lower 
public health priority previously given to childhood TB.” 
4, 9
 
While culture remains the gold standard for diagnosing TB in children, recent advances 
like GeneXpert MTB/RIF assays have improved the turnaround time for diagnosis. 
11 
 
These tests can also be used for testing gastric aspirate and urine and once fully 






2.5 SUMMARY OF CHAPTER 
The reviewed literature in this chapter reflects the small number of studies and data 
available on the epidemiology of childhood TB globally and in South Africa or other 
high burden countries. Studies that have been conducted in other countries are not in 
the same high burden setting and not typical of the South African context. 
13 
 
3 CHAPTER III: METHODS 
3.1 INTRODUCTION 
The importance of understanding the epidemiology of TB in children is key to managing 
the TB epidemic. The paucity of studies in South Africa of TB in children has made this 
difficult. This study describes the demographic profile of childhood TB in South Africa 
between 2008 and 2012. In Chapter Three, the research methods used in this study are 
described, including the study design, study population and sampling, data collection, 
and analysis. Ethical considerations, which apply to this study, are also described. 
3.2 CONCEPTUAL FRAMEWORK 
The conceptual framework for this study has its foundation in the outcome of the 
treatment as this influences the future health of the child. The clinical outcomes of 
children 0 to 14 years diagnosed with TB through the lens of various demographic 
factors like age, sex and HIV status is reported, in an attempt to identify possible 




Figure 1: Conceptual Framework2 
3.3 TYPE OF RESEARCH 
This study involves epidemiological research, which will be applied at a public health 
level, in order to assist in informing the design of appropriately targeted community 
based interventions to reduce the burden of childhood TB in SA. 
3.4 STUDY DESIGN 
An observational analytical cross sectional study design was used. 
3.5 TARGET POPULATION 
The results of this study are generalizable to all children aged less than fifteen years in 
South Africa as well those in other low to middle income countries in Africa with a 
similar demographic profile and burden of HIV infection. 
                                            
2 This conceptual framework is self-designed based on personal experience in the TB programme 
15 
 
3.6 STUDY POPULATION 
The study population comprised all children reported with TB, and diagnosed by means 
of bacteriological, radiological or clinical findings and recorded in the ETR.Net in South 
Africa for the 5-year period from 2008 to 2012. A census was used of all records of TB 
patients aged 0 to 14 years between 2008 and 2012. (N=235 836). 
Inclusion Criteria: 
All children in the age groups 0 to 4, 5 to 9 and 10 to 14 years reported on TB treatment 
in the ETR.Net with drug sensitive TB between 2008 and 2012, irrespective of the 
diagnostic method or the site of the disease were included in the study population. 
Exclusion Criteria: 
The following criteria were applied for excluding study participants from the study: 
1. TB patients 15 years and older; and 
2. Children aged 0 to 14 years with drug resistant TB. 
3.7 DATA SOURCES 
The Electronic TB Register was used as the source of the data. Records from 1 January 
2008 to 31 December 2012 were used. The ETR.Net is the software used by the South 
African National Department of Health to capture routine patient level data for drug 
sensitive TB in all public health facilities. 
3.8 VARIABLES 
3.8.1 Reliability and Validity of Data Source 
The ETR.Net was used as the data source. While it is acknowledged that there are data 
quality issues with any clinician-recorded data, it remains the most reliable source of 
data on childhood TB in South Africa. 
16 
 
3.9 BIAS AND LIMITATIONS 
To minimize selection bias all records were included and duplicate records were 
removed. Information bias has been minimized by automatic importing of the 
data from the electronic TB database into the statistical software thereby 
minimizing human capture error. It is acknowledged that there is potential for 
information bias with any clinician- recorded data. The database has incomplete 
data records for certain reporting variables and for some reporting periods. This 
was taken into account during analysis. 
3.10 STATISTICAL PROCESSING 
3.10.1 Descriptive statistics 
A descriptive summary of the age groups and demographic factors as well as 
the outcomes per province is presented in Chapter Four. 
3.10.2 Analytic statistics 
The data, which was available in a Structured Query Language (SQL) database, was 
exported into MS Excel and imported into a statistical software package (STATA 
13) for processing and analysis. Chi square analysis was used to determine odds 
ratios and risk ratios and logistic regression was used to control for confounding. 
Pearson’s Chi squared test was used for trend analysis. The results of this analysis of 





3.11 LIST OF ASSOCIATIONS ASSESSED 
Various associations between variables have been measured as per Table 1 below. 
Table 1: List of possible associations 
.Variable Possible Associations 
Sex Nil 
Age Clinical Outcomes, HIV status 
Type of TB Clinical Outcomes, HIV status 
HIV status Clinical Outcomes, Age 
3.12 ETHICS AND PERMISSIONS 
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3.13 SUMMARY OF CHAPTER 
This study investigated the epidemiological profile of children aged 0 to 14 years with 
TB in South Africa from 2008 to 2012, as well as association of some demographic 
variables with possible outcomes. In this chapter the study design, study population and 
sampling, data collection and analysis that were employed in the study are described. 




4 CHAPTER IV: RESULTS 
4.1 INTRODUCTION 
Data was extracted from the ETR.Net and imported into STATA 13. Frequency distribution 
tables were generated and bivariate analysis performed to measure associations between exposure 
and outcome variables. Microsoft Excel was used to generate graphs. The database has 
incomplete records for certain reporting units and for some reporting periods. This has been noted 
in detail and analysis has been controlled to minimize the effect on the results. 
4.2 PRESENTATION OF DATA 
4.2.1 Age of children with TB 
There were 384 936 children (< 15 years) diagnosed with TB and recorded in the ETR.Net in the 
five year period (Table 2). More than two-thirds of the children with TB (266 987 - 69%) were in 
the 0 to 4 year old age group. 
 
Table 2: 4.1 Age groups of children recorded with TB in SA, 2008-2012 
Age Group No. % 
0 to 4 years 266 987 69 
5 to 9 years 76 138 20 
10 to 14 years 41 811 11 





This data was then categorized per year in order to determine trends in the number of children 
diagnosed with TB within the three age group categories (Table 3). The proportion reported 
from the ETR.Net within each age group remained consistent across the study period. It ranged 
from 67% to 71% in the 0 to 4 age group, from 19% to 22% in the 5 to 9 age group and from 
10% to 11% in the 10 to 14 year old age group. No obvious trend was observed in the data. 
 




        Year           
2008 2009 2010 2011 2012 
 No. % No. % No. % No. % No. % 
0 to 4 47 381 67 65 460 71 53 574 70 55 219 69 45 353 69 
5 to 9 15 425 22 17 315 19 14 892 19 15 814 20 12 692 19 
10 to 14 7933 11 9215 10 8278 11 8713 11 7672 12 




4.2.2 Distribution of males to females 
The distribution of males to females in the age groups 0 to 4 years and 5 to 9 years consistently had a slightly higher proportion of males than 
females. In the age group 10 to 14 years, the opposite was found with a higher proportion of females reported than males. Both patterns appear 
consistent over the five-year period (Table 4). 
Table 4: Distribution across age groups of males and females less than 15 years reported with TB from 2008 to 2012 
Year 
  0 to 4 years     5 to 9 years     10 to 14 years 
  Total 
Female   Male   Female Male   Female Male 
2008 22 
878 
48% 24 501 52% 7619 49% 7806 51% 4281 54% 3652 46% 70 737 
2009 31 
798 
49% 33 661 51% 8488 49% 8827 51% 5111 55% 4104 45% 91 989 
2010 26 
031 
49% 27 543 51% 7312 49% 7580 51% 4519 54% 3759 46% 76 744 
2011 26 
816 
49% 28 403 51% 7830 50% 7984 51% 4747 54% 3966 46% 79 746 
2012 22 
076 
49% 23 277 51% 6222 49% 6470 51% 4057 53% 3615 47% 65 717 
Total 129 599 49% 137 385 51% 37 471 49% 38 667 51% 22 715 54% 19 096 46% 384 933 
4.2.3 Proportion of children diagnosed with TB 
A total of 1 882 139 cases of TB were reported in South Africa from 2008 to 2012, of which 384 936 (21%) were aged 0 to 14 years (Table 4). 





Table 5: Children diagnosed with TB as a proportion of all TB cases reported in the same period, 2008 to 2012 
Age Group 
(years) 
2008 2009 2010 2011 2012 
  No. % No. % No. % No. % No. % 
0 to 4 47 831 13% 65 460 16% 53 574 15% 55 219 14% 45 353 13% 
5 to 9 15 425 4% 17 315 4% 14 892 4% 15 814 4% 12 692 4% 
10 to 14s 7933 2% 9215 2% 8278 2% 8713 2% 7472 2% 
All children 71 189 19% 91 990 22% 76 744 21% 79 746 20% 65 517 19% 
Total 15+ 
years 
297 457 81% 319 734 78% 282 217 79% 313 468 80% 284 077 81% 
Total TB 368 646 100% 411 724 100% 358 961 100% 393 214 100% 349 594 100% 
4.2.4 Treatment category 
A total of 292 185 children were newly diagnosed with TB in the five year period (Table 6). The proportion of children with TB that were not 
classified according to disease history ranged from 12% to 19% over the five-year period. The proportion in children reported having had 
previous TB remained largely unchanged. Knowing the previous TB history of the child is important to assess risk of possible drug resistance 
and to determine the regimen of treatment for the child. 
Table 6: History of previous TB of reported cases from 2008 to 2012 
Category 
2008 2009 2010 2011 2012 Total 
No. % No. % No. % No. % No. % No. % 
New 59590 84% 66659 73% 55104 72% 59825 75% 51007 78% 292185 76% 
Re-treatment 2607 4% 2609 3% 2368 3% 2593 3% 1968 3% 12145 3% 
Not 
Classified 
8542 12% 22722 25% 19272 25% 17328 22% 12742 19% 80606 21% 
Total 70739 100% 91990 100% 76744 100% 79746 100% 65717 100% 384936 100% 
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Between 2008 and 2009, there was a huge increase in the proportion of children with 
TB whose previous history of TB was not categorised. Since 2009, this proportion has 
shown a decreasing trend from 25% in 2009 to 19% in 2012 (Figure 2). 
 
Figure 2: Children with TB whose previous history of TB was not classified from 2008 to 2012. 
4.2.5 Bacteriological Coverage 
Bacteriological coverage varied between the age groups with the highest coverage 
found in the 10 to 14 year old age group. The coverage in the 5 to 9 year old age group 
ranged between 21% in 2008 and 33% in 2012. This is very low as most children in this 
















Figure 3: Bacteriological coverage of children reported with PTB from 2008 to 2012 
 
4.2.6 Type of TB 
The majority (284 556 -93%) of children classified according to the type of TB, in the five-year 
period had pulmonary TB (PTB). There were 19 757 (7%) of children with extra pulmonary TB 
(EPTB) reported over the five year period. This ranged from 4156 (7%) children in 2008 to 3351 
(6%) in 2012. The downward trend trend of children reported with EPTB was significant, (0.035) 
(Table 7). In the case of HIV positive children reported with EPTB, it is noted that in the age 
groups 0 to 4 years, there is a significant trend in the decrease in the proportion of children with 
EPTB (p=<0.0001). 
This decrease is mirrored in the 5 to 9 year age group (p <0.0001) and less strongly in the age 
group 10 to 14 years, although the trend is still significant (p = 0.003) (Table 8). 





  No. % No. % 
2008 4156 7% 58 028 93% 62 184 
2009 4385 6% 64 880 94% 69 265 
2010 3746 6% 53 725 94% 57 471 
2011 4119 7% 58 299 93% 62 418 
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2012 3351 6% 49 624 94% 52 975 
P value 0.035         
Total 19 757 7% 284 556 94% 304 313 
 





Table 8: Proportion of children reported with EPTB that are HIV positive from 2008 to 2012 
  0 to 4 years 5 to 9 years 10 to 14 years All children <15 years 






Positive % CI 95% Positive % 
CI 
95% 
2008 202 49% 42 - 56 198 59% 52 - 66 137 39% 31 - 47 537 33% 29 - 36 
2009 452 52% 47 - 57 363 61% 56 - 66 310 51% 45 - 57 1125 35% 32 - 38 
2010 396 41% 36 - 46 437 59% 54 - 64 383 47% 42 - 52 1216 33% 30 - 36 
2011 406 35% 30 - 40 463 56% 52 - 61 523 49% 45 - 53 1392 31% 29 - 33 
2012 322 32% 27 - 37 348 48% 43 - 53 450 49% 44 - 54 1120 30% 27 - 33 
P 
Value   
  <0.000       <0.000     0.003     <0.000   
Total 1778 40% 1809 56% 1803 48% 5390 32% 
 
4.2.7 HIV testing 
The proportion of children with TB who were tested for HIV increased progressively from 22% (15 
478) in 2008 to 72% (47 379) in 2012 (Table 10), which increased across all age groups during the 
period (Figure 4). 





  No. % 
2008 70 739 15 478 22% 
2009 91 990 31 468 34% 
2010 76 744 38 950 51% 
2011 79 746 50 770 64% 
2012 65 717 47 379 72% 
5 Year 
Total 
384 936 184 045 48% 
 










During the five-year study period 184 045 (48%) children with TB were tested for HIV, of which 58 876 (32%, 95% CI: 31.8 to 32.2) tested 
positive (Table 10). A Pearson’s Chi squared test was used to determine if there is a significant change in the data over time. The trend in HIV 
prevalence is increasing in each of the three age group category. In the 10 to 14 year category HIV prevalence increased from 33% (95% CI 
31.7 - 35.1) in 2008 to 51% (95% CI 49.9 - 52.3) in 2012 and the increase is statistically significant (p= <0.000). There were decreases in both the 
children aged 0 to 4 years and 5 to 9 years (Table 10). 
Table 10: Trends in HIV prevalence in children <15 years diagnosed with TB from 2008 to 2012 
Year 
  0 to 4 years     5 to 9 years   10 to 14 years All children <15 
years 









2008 3150 37%  35 - 38 1879 48% 46 - 50 1029 33% 30 - 36 6058 39% 38 - 40 
2009 6138 32%  30 - 33 3618 49% 47 - 51 2087 43% 41 - 45 11843 38% 37 - 39 
2010 6394 27%  25 - 28 4521 50% 49 - 52 2832 50% 48 - 52 13747 35% 34 - 36 
2011 6438 20%  19 - 21 4968 44% 43 - 45 3414 50% 48 - 52 14820 29% 28 - 30 
2012 5193 17%  16 - 18 3947 40% 39 - 42 3268 51% 49 - 53 12408 26% 25 - 27 
  P value<0.000     <0.000   <0.000   <0.000   
Total 27313 24%   24 - 25 18933 45% 44 - 46 12630 47% 46 - 48 58876 32% 32 - 32 
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The percentage of children with TB that were tested for HIV rose consistently 
while the prevalence of HIV leveled off in the age groups 0 to 4 years and 5 to 9 
years but continued to rise in the children aged 10 to 14 years (Figure 5). 
 

































4.2.8 Treatment Outcomes 
Tuberculosis outcomes are categorised as “treatment success”, “default”, “death”, and “failure”. Outcomes of “transferred” and “moved” 
and “not evaluated” have been removed from the denominator. The proportion of children who successfully completed treatment increased 
from 90% (95% CI 89.5 - 90.1) to 93% (95% CI 92.8 - 93.4) from 2008 to 2012. This is statistically significant if measured against a 
combination of unsuccessful outcomes (p<0.0001) The proportions of those who died and those who defaulted treatment showed slight 
decreases while the proportion who failed treatment remained unchanged (Table 11). 
Table 11: Trends in treatment outcomes of children with TB reported from 2008 to 2012 
Year Treatment Success Defau
lted 
    Died     Failed 
  No. % 95% CI No. % 95% CI No. % 95% CI No. % 95% CI 
2008 41 413 90% 89.5 - 90.1 2971 6% 6.2 - 6.6 1568 3% 3.2 - 3.6 157 0.30% 0.25 - 0.35 
2009 44 653 91% 90.2 - 90.8 2984 6% 5.8 - 6.2 1585 3% 3.0 - 3.4 144 0.30% 0.25 - 0.35 
2010 35 452 91% 90.3 - 90.9 2348 6% 5.8 - 6.2 1218 3% 2.9 - 3.3 113 0.30% 0.25 - 0.35 
2011 41 583 93% 92.7 - 93.1 2005 5% 4.3 - 4.7 1011 2% 2.2 - 2.4 145 0.30% 0.25 - 0.35 
2012 34 843 93% 92.8 - 93.4 1673 5% 4.3 - 4.7 791 2% 2.0 - 2.3 106 0.30% 0.2 - 0.4 
P 
value 
  <0.000                     





Using the age group 0 to 4 years as the reference group, risk ratios were calculated for clinical 
outcomes of successful treatment. The age group 0 to 4 years was used because it is the largest 
group. It was found that all children had a significant chance (p<0.01) of treatment success 
irrespective of age, 1.01 for 5 to 9 years and 0.99 for 10 to 14 years (Table 12). 
Table 12: Risk ratio for the outcome successful treatment per age group from 2008 to 2012 














0 to 4 years 121 138 132 890 0.912 Reference   
5 to 9 years 50 505 54 653 0.93 1.014 1.011-1.017 <0.01 
10 to 14 
years 
26 301 29 220 0.9 0.987 0.983-0.992 <0.01 
Total 197 944 216 763         
In terms of the clinical outcome of death, the children aged 5 to 9 years had 21% (0.79) less risk 
of death compared to the children less than 5 years (p<0.01) whereas the age group 10 to 14 had 
1.33 times the risk of death (P<0.01) (Table 13). 
Table 13: Risk ratio for the clinical outcome of death per age group for children reported with TB 
from 2008 to 2012 








95% CI p-value 
     
    
0 to 4 years 3812 132 890 0.029 Reference 
5 to 9 years 1246 54 653 0.023 0.79 0.75-0.85 <0.01 
10 to 14 
years 
1115 29 220 0.038 1.33 1.25-1.42 <0.01 
Total 6173 216 763         
Both children aged 5 to 9 and children aged 10 to 14 have a significantly greater risk of testing 
positive for HIV, 1.9 times (p<0.01) and 2.0 times (p<0.01) respectively (Table 14). 
Table 14: Risk ratio for testing HIV positive per age group from 2008 to 2012 




    
Age Group Positive Negative Total 95% CI 
p-
value 
0 to 4 years 27 313 88 135 115 
448 
0.237 Ref group   
5 to 9 years 18 933 22 817 41 750 0.453 1.92 1.89-1.95 <0.01 
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10 to 14 
years 
12 630 1217 26 847 0.47 1.99 1.96-2.02 <0.01 
Total 58 876 112 169 184 
045 
        
4.3 SUMMARY 
The results of the analysis show clearly the demographic picture of childhood TB in each age 
group over the five-year period as well as changes in trends of HIV testing for childhood TB as 
well as HIV prevalence trends. 
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5 CHAPTER 5: DISCUSSION 
5.1 INTRODUCTION 
In this chapter, the results of this study looking at the epidemiology of childhood TB cases reported 
in South Africa from 2008 to 2012 is discussed. Associations between variables are examined to 
identify any that may be of statistical significance. The results are compared to existing knowledge, 
and possible explanations for the findings are provided. The study findings are also considered in 
light of the possible biases and limitations of the study design, the data collection process and 
results obtained in the study. 
5.2 AGE GROUPS 
Most (69%) of reported cases of childhood TB in South Africa from 2008 to 2012 were younger 
than 5 years old and only 11% were from  the 10 and 14 years aged group. 
This is consistent with two studies from the Western Cape where the burden of childhood TB was 
also in the youngest age group. Van Rie et al. 
14 
found that children aged 0 to 4 years comprised 
79% of the total cases of childhood TB during the period 1985 to 1994 and Marais reported that 
5% of children with TB were less than 3 years old. All three South African studies found higher 
proportions than those of the two Indian studies where Mazta and Bandichhode reported 
proportions of 3.9% and 37% respectively in this age group. Data comparison is made difficult by 
the use of slightly different age groupings in each of these reported studies. 
The studies by Van Rie et al. examined data from 1744 cases of TB in children from two 
communities, Mazta et al. studied data from 541 cases, Bandichhode et al, 93 cases and Marais et 
al, 443 cases. These studies were limited to small communities or district areas where factors such 
as health policy or health staff competency and capacity may have influenced the results. Our study 
examined data from 266 987 cases reported from the whole country. There could be random 
variation when the sample population is small, which could be a reason for the difference in 
proportions reported across the different studies. 
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5.3 TREATMENT CATEGORY 
Most of the children with TB were reported to be the first episode of disease. The proportion being 
first episode cases ranged from 84% of the total cases in 2008 to 78% in 2012. This is not 
remarkable considering these were all young children. There was however, an increasing trend in 
the proportion of childhood TB who were non- classified. These cases increased from 12% in 2008 
to 19% in 2012. Non-classification may be attributed to poor history taking skills or poor recording 
of data in the patient files and Electronic TB registers, which is the basis of the dataset used in this 
study. 
5.4 BACTERIOLOGICAL COVERAGE 
The proportion of childhood TB with a bacteriological diagnosis varied between the age groups. 
The 10 to 14 year old age group had the highest bacteriological coverage. The coverage in the 5 to 
9 year old age group ranged between 21% in 2008 and 33% in 2012, which is very low as most 
children in this age group could be expected to produce a sputum samples. Failure to implement TB 
guidelines, lack of knowledge of the health staff and lack of patient education may have contributed 
to this low proportion with bacteriological coverage. In poor resource settings, anecdotal data 
indicates that laboratory transport systems are irregular and samples often are leaked or spoiled by 
the time specimens arrive at the laboratory. 
5.5 TYPE OF TB 
Poor data quality and missing data is reflected in the analysis of the type of TB in children in the 
ETR.Net. In 21% of the 384 936 cases, the site of disease was not classified. The highest 
proportion (30%) of childhood TB cases not classified occurred in the children in the under 5-year 
age group. Incomplete recognition of the type of TB may be due to a lack of understanding of the 
International Classification of Disease 10
th 
revision (ICD 10) codes used to record the type of TB 
disease in the registers. Most (284 556 - 94%) of children in this study were classified as having 
pulmonary TB (PTB). This finding is similar to other studies reported in SA.  Van Rie reported that 
98% of children with TB in the Western Cape reported having had PTB. However, both Indian 
studies reported lower proportions (55%) and (68%) with PTB and higher proportions with extra-
pulmonary TB (EPTB). 
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There were 19 757 (7%) children with EPTB reported over the five year period. This ranged from 
4156 (7%) children in 2008 to 3351 (6%) in 2012. The trend of EPTB registrations showed 
significant decrease (p = 0.035) over the five year period. In children reported to be living with HIV 
reported with EPTB, it is noted that in the age groups 0 to 4 years, there is a significant decreasing 
trend in the proportion of children with EPTB (p=<0.0001 for trend). This decrease is mirrored in 
the 5 to 9 year age group (p <0.0001 for trend) and less strongly in the age group 10 to 14 years, 
although the trend is still significant (p = 0.0029). A study in India reported EPTB in 15 to 20% of 
HIV-negative children with TB and 20 to 70% of those HIV infected, while in a Thai study, 40% of 
HIV-infected children with TB reported as having EPTB. 
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5.6 HIV TESTING AND COUNSELING (HTC) 
South Africa has actively promoted HIV testing and counselling for patients with TB with 
particular emphasis since the HTC campaign launched in 2010. 
30 
As a result, the trends in the 
proportion tested annually increased from 18% in 2008 to 68% in 2012. The largest increase in the 
proportion tested was in the children aged 10 to 14 years. Using the age group 0 to 4 years as a 
reference group, it was found that children aged 5 to 9 years had 1.27 times higher probability of 
being tested for HIV, while those aged 10 to 14 had a 1.48 times higher probability of accessing 
HTC. This is encouraging as it appears that implementation of national HTC policy has increased 
access to HIV care for children with TB. Children aged 0 to 4 years should have been tested as part 
of the Prevention of Mother-to-Child Transmission programme (PMTCT), where mothers are 
tested during pregnancy and children born to HIV infected mothers are tested at 2 months and 18 
months of age. 
5.7 HIV PREVALENCE IN TESTED CASES 
During the five-year study period 184 045 (48%) children with TB were tested for HIV, of which 
58 876 (32%, 95% CI: 31.8% to 32.2%) tested positive. A Pearson’s chi squared test was used to 
determine if there is a significant change in the data over time. 
The trend in HIV prevalence in the 10 to 14 year category HIV prevalence increased from 33% 
(95% CI 31.7 - 35.1) in 2008 to 51% (95% CI 49.9 - 52.3) in 2012 and the increase is 
statistically significant (p= <0.0001). There were decreases in the HIV prevalence both the 
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children aged 0 to 4 years and 5 to 9 years. The proportion of HIV positive cases over the whole 
sample has steadily decreased over the five year period from 39% in 2008 to 26% which is 
statistically significant (p<000.1). It is unclear if this is due to fewer children being infected with 
HIV, or poorer implementation of Department of Health policy requiring 100% HIV screening 
and therefore reduced HIV testing of symptomatic or ill children only. 
In looking at the data broken into age groups it can be observed that in the age group 5 to 9 years 
the proportion of children with TB tested for HIV increased from 26% to 78% over the five-year 
period while the proportion of those HIV positive decreased from 48% to 40% over the same 
period. In the age group 10 to 14 years however, while HIV testing increased from 39% to 83%, the 
proportion of HIV positive cases increased from 33% to 51%. No comparative studies could be 
found to compare these findings. 
The high numbers of HIV positive cases in the age group 10 to 14 years in SA is of concern. Some 
of these children would not have had access to the PMTCT programme and therefore the virus may 
have been transmitted from mother to child during pregnancy and birth or breastfeeding, or it may 
indicate HIV infection at a young age due to early debut into sexual intercourse. Using the age 
group 0 to 4 years as the reference group, it was found that children aged 5 to 9 years had 1.92 
times higher risk of being HIV positive while children aged 10 to 14 years had almost double the 
chance of being HIV infected (1.99). The proportion of children tested for HIV over the five-year 
period (48%) was lower than that reported by Marais in 2006 for children with TB in the Western 
Cape where 65% had been tested. In the Western Cape, this had reached 83% by 2012 indicating a 
nationwide improvement in access to HTC. The prevalence of HIV in children with TB was 32% 
nationally, which was much higher than that found by Marais in the Western Cape of 8.8%. 
5.8 TREATMENT OUTCOMES 
The outcomes of “successful treatment” and “death” were analysed in children with TB who had 
outcomes recorded at the end of treatment. Outcomes of “transferred out” “moved out” and “not 
evaluated” were removed from the denominator. Over the five- year period, the treatment success 
for children with TB was 91%, which is above the national target of 85%. Successful TB outcomes 
reported ranged from 90% in the age group 10 to 14 years to 92% in the 5 to 9 year olds. Hailu et 
al. 
31 
found that the treatment success was 85%, which was similar to this study and above the 
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target of the WHO. Once again, the incompleteness of the data meant that there was a high 
proportion of outcomes that could not be evaluated. In terms of the reliability of the results of this 
study, this is of concern. Lack of reported TB outcomes is of particular concern in the under-5 age 
group where 33% of outcomes could not be evaluated. This is much higher than that of the 
Ethiopian study where only 4.9% of the records had no treatment outcome recorded. This 
potentially skews the proportions and makes it difficult to assess the true performance of the TB 
programme in South Africa. 
Treatment outcomes have lower than expected reported proportions of defaulting from therapy and 
treatment failures, but these may be hidden in the large proportion of cases with no recorded 
outcomes. Using the age group 0 to 4 years as a reference group, children aged 5 to 9; and 10 to 14 
years have no significant difference in probability of successfully completing treatment. This 
differs from a retrospective data analysis of 2708 records by Hailu et al. 
31 
conducted in Ethiopia 
from 2007 to 2011. The Ethiopian study found that the age group 5–9 years [AOR= 2.5 (95% CI 
1.7-3.7)] and 10–14 years [AOR = 2.7 (95% CI 1.9-3.9)] were independently associated with 
successful treatment outcomes. 
In the case of those who died, children aged 5 to 9 have a 21% lower risk of dying while the age 
group 10 to 14, have a 1.33 times higher risk of dying. In this study the proportion of children with 
TB who were reported to have died was 3% which was the same proportion found by Hailu. 
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5.9 BIAS AND CONFOUNDING 
5.9.1 Bias  
Selection bias 
Selection bias was minimized by the identification and management of duplicate records 
and the fact that a census of all records was used. The database had incomplete records for 
certain reporting units and for some reporting periods. This has been noted in the 




Information bias was minimized by automatic importing of the information from the 
electronic TB database into the analysis software thereby minimizing human capture error. 
Poor data quality in terms of incomplete records has been noted and discussed. These 
incomplete records may result in skewed results for those periods or reporting units. 
5.9.2 Confounding 
Confounding variables have been identified and controlled for by stratifying into age 
groups to minimise effect on the results. 
5.10 EFFECT MODIFICATIONS 
Effect modification was controlled for by stratification into age groups to ensure that 
positive associations for specific subgroups were not disguised within the whole. 
5.11 LIMITATIONS OF RESULTS AND STUDY DESIGN 
This study used routine data and therefore patients that are not reported but that may have 
been on treatment were not included e.g. those being treated in the private sector. The study 
was limited by the quality of the routine records used. There was a large number of 
incomplete records for some reporting units as well as for some reporting periods, which was 
a major limitation. Due to the large number of records, it was not possible to verify data from 
individual patient files. 
5.12 SUMMARY OF CHAPTER 
This study describes the epidemiology of childhood TB in South Africa over a five-year period 
with respect to several variables. Analysis of the caseload per age group revealed that the 
South African profile follows the trends experienced in other countries. The data reveals an 
implementation of national policy and a rising proportion of HIV positive cases particularly in 
the age group 10 to 14 years. 
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6 CHAPTER VI: CONCLUSIONS AND RECOMMENDATIONS 
6.1 INTRODUCTION 
The proportion of childhood TB cases is a recognised indicator for the size of the infectious pool of 
TB in a population. It is also seen as an indicator of the quality of TB control. As a high burden TB 
country, understanding the epidemiology of childhood TB in South Africa has become increasingly 
important to enable better management of the TB epidemic. In particular, the age group 10 to 14 
years are seen as a vulnerable group and this study provides important insight into their 
epidemiological profile. 
6.2 CONCLUSIONS 
The study has revealed that the proportion of childhood TB cases is within the upper limit of the 
range of WHO’s expected proportion for high burden countries of 10 to 20%. It can also be seen 
that while advances have been made in the implementation of the policy for 100% HIV testing for 
all TB cases, this is still lagging behind the target in terms of children with TB. The poor quality of 
recording and incompleteness of recording has the potential to skew the results as well as 
undermine the health outcomes of the patients who may be lost to follow up. The high numbers of 
HIV positive cases in the age group 10 to 14 years is of concern. It is clear that this subgroup will 
need particular attention. Treatment outcomes are difficult to establish as the large proportion of 
cases with no recorded outcome may hide the true picture. 
6.3 RECOMMENDATIONS 
Based on the findings of this study the following recommendations are made: 
1. Case finding is below expected 
 Improve antenatal care for pregnant women to include TB screening and 
identification of household contacts particularly those under 5 years. 
 Screening of infants with mothers having TB 
 Include routine TB screening in all contacts with children. 




2. Bacteriological coverage is low 
 Implement training programmes for health staff on gastric lavage and other 
methods for encouraging the production of sputum in children. 
3. Routine HIV testing for children 
 Capacity building of nurses in adherence to the national TB guidelines with 
regard to HIV screening for all TB cases. 
 Ensure that all HIV exposed infants (those born to HIV positive mothers) are tested 
for HIV at 2 months and at 18 months of age. 
 Ensure that all children attending a public health facility are screened for HIV. 
4. Specific prevention programmes for children aged 10 to 14 years 
5. Targeted youth friendly interventions for adolescents aged 10 to 14 years focusing 
on screening, prevention, retention in care 
6. Poor recording and reporting 
 Monitoring and supervision by the operational managers at facilities with regard to 
data quality and completeness of recording. 
 Capacity building of clinicians in ICD-10 codes, reporting, and recording in the TB 
register is essential to correct the poor completeness of records. 
 Regular feedback on progress towards targets in order to focus interventions on areas 
of poor performance and thus improve service delivery and programmatic 
performance. 
  
7 Implement practical training on other methods of diagnosing TB in children. E.g. the 
utilisation of the triad approach of the triad of (1) known contact with an adult index 
case, (2) a positive tuberculin skin test (TST) as evidence of latent tuberculosis infection 
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1 Abstract 
Childhood tuberculosis has gained increasing focus in recent years due to the 
recognition of the contribution of the disease to morbidity and mortality in children. 
Previous studies have shown that the burden of TB disease in South Africa may 
mirror the high burden of the adult epidemic, although systematic reporting on 
childhood TB has been absent. 
This chapter looks at an analysis of data from the Electronic TB Register to examine 
the characteristics of childhood TB (0-19 years) in South Africa over the five-year 
period 2008-2012. 
Childhood cases represented 15.3% of all TB cases in South Africa in 2012, with the 
majority of cases in the 0-4 years age group, similar to trends found in the majority of 
countries. The five-year trends reflect the influence of national HIV Counselling and 
Testing policies implemented during the same period. The basis for diagnosis has 
historically leaned towards radiology due to the difficulty of obtaining microscopy 
specimens; while this still holds true for children aged 0 to 4 years, there has been a 
consistent increase in the proportion of children with microscopy results.  
Clinical outcomes are generally better than for adult TB patients, with all age groups 
achieving a successful completion rate in excess of 80%. The defaulter rates are 
correspondingly lower than in adults, with the 15 to 19 years age group having the 
highest defaulter rates. 
2 Introduction 
Tuberculosis (TB) has increasingly been recognised as a major cause of morbidity 
and mortality among children in high TB-burden settings.i,ii,iii Graham et al poignantly 
highlighted the importance of TB control in addressing child survival, relating this to 
Millennium Developmental Goal 5.iii Although there are limited data on TB 
adolescents, they are noted to be an important group at risk for TB infection.ii A 
cross-sectional study in a high TB-burden setting in Cape Town reported that the 
force of infection with mycobacterium tuberculosis increased from 3.96 at age 10 
years to 6.63 at 19 years, indicative of a high TB burden, even in this age group.iv 
The Child TB Roadmap calls for strengthened reporting of TB cases occurring in 
children by national TB programmes, and among its 10 key actions are (i) inclusion 
of the needs of children and adolescents in research, policy development and clinical 
practice, and (ii) collection and reporting of better data, including data on preventive 
measures.ii 
 
This chapter presents selected trends in TB in children and adolescents (0-19 years) 
in South African provinces from 2008 to 2012. Data were derived from the national 
drug-sensitive TB electronic database (ETR.net). As expected from routine data, 
there are concerns about certain aspects of data quality. Data were known to be 
incomplete for 2008 (Mpumalanga and KwaZulu-Natal) and 2010 (Gauteng) due to 
database management problems which resulted in the loss of some patient records. 
This impacts primarily on case-finding numbers, and to a lesser extent on treatment 
outcomes and results presented in percentage form.  
 
Data on the demographic profile of TB across the country are presented, followed by 
a report on case-finding and treatment outcome data.  
3 Demographic profile 
3.1 Age group distribution 
In Figure 1 it can be seen that the distribution of cases in the age groups 0-4 years, 
5-9 years, 10-14 years and 15-19 years has remained fairly constant between 2008 
and 2012, with the largest distribution being in the 0-4 year age group and the lowest 
distribution being in the 10-14 year age group, as expected. 
 
Figure 1: Age distribution of TB case finding, 0-19 years, as a percentage of 
total cases 
 
The distribution of cases by age group aligns closely with the general provincial 
picture for all TB case-finding, with the high-burden provinces of KwaZulu-Natal 
(KZN), Eastern Cape (EC) and Western Cape (WC) also having the highest load of 
cases in the age group 19 years and under (Figure 2). The data losses experienced 
by the provinces can be seen on these graphs; Gauteng Province (GP) is clearly 
illustrated, while Mpumalanga Province  (MP) and KZN are less obvious.   
 
Figure 2: Percentage of cases by province for children (0-19) and all other 
ages, 2008-2012 
 
3.2 Distribution of males to females: 
Table 1 shows the distribution of males and females. In the age groups 0-4 and 5-9, 
there are more males than females being diagnosed, whereas this balance shifts in 
the 10-14 and 15-19 year age groups. This pattern may be attributed to the 
increased risk of HIV infection as the child gets older and hence a more typical 
pattern following the trend of the more female-driven HIV and AIDS epidemic. This 
could also reflect health-seeking behaviours in males who are known to attend 
health facilities to a lesser degree than do females.v,vi The pattern remains constant 
in 2008 and 2012 as shown in Figure 3. Males do outnumber females in all these 
age groups in the population, however the pattern of slightly higher incidence (TB 
case-finding per 100 000 population) among males in the 0-4 and 5-9 age groups 
remains, as does the shift to higher incidence in females in the 10-14 and 15-19 age 
groups (Table 2). 
Table 1: Distribution of case finding by gender in children, 2008-2012 
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Table 2: Incidence of TB (case finding per 100 000 population) by gender in children, 
2008 and 2012 
  2008 2012 
 Age Male Female Male Female 
Population 0-4 2 603 490  2 570 453  2 667 566  2 627 718  
5-9 2 567 947  2 551 336  2 547 643  2 529 309  
10-14 2 607 728  2 592 210  2 546 776  2 540 948  
15-19 2 516 392  2 495 721  2 586 968  2 577 001  
Incidence 0-4 617.3 582.7 484.0 457.5 
5-9 235.1 236.4 189.2 184.2 
10-14 106.6 128.1 102.9 120.0 
15-19 223.7 332.7 213.6 299.7 
Source: Stats SA mid-year estimates times series (released with 2013 estimates) 
and ETR.net. 
 
Figure 3: Age pyramids of TB case finding in children, 2008 and 2012 
 




















3.3 HIV status 
The testing of TB patients for HIV has gained momentum in recent years following 
changes in the National Department of Health policies. This is reflected in the 
decreased percentage of cases where the HIV status is unknown from 2008 to 2012 
as shown in Figure 4. Cases where HIV status is unknown have dropped by more 
than half across all age groups 0-19 years.  
 
Figure 4: Percentage of cases with HIV status unknown by age group, 2008-2012 
 
The positivity rate has increased proportionally by more than double across all age 
groups, as seen in Figure 5, as a result of the substantial improvement in testing for 
HIV status. 
 
Figure 5: Tree-map showing the number (size) and percentage (label) of TB cases 
according to HIV status by age group, 2008 and 2012 
 
 
The greatest increase in TB-HIV cases was found in the age group 10-14 years 
(11.9% of all cases in this age group in 2008 to 39.9% in 2012). When considering 
only the cases where the HIV status was known, the highest HIV prevalence was 
also in the 10-14 year age group in 2012 (Table 3). The trends are difficult to 
interpret due the change in the proportion of cases with known HIV status over the 
period. 
Table 3: Percentage HIV+ of those with known HIV status, by age group, 2008-2012 
 2008 2009 2010 2011 2012 
0-4 36.54% 34.40% 29.32% 22.42% 19.39% 
5-9 45.50% 46.33% 47.02% 41.68% 38.45% 
10-14 30.76% 39.21% 47.10% 47.59% 49.10% 




The WHO estimates that in high-burden settings, childhood TB cases comprise 10-
20% of the total TB caseload.ii Until the last decade, TB reporting has largely been 
focused on smear-positive cases known to drive transmission. Hence childhood TB 
was overlooked and data on childhood TB were limited since most cases are smear-
negative. Age-specific estimates of TB incidence (including an adjustment for smear-
negative cases) based on TB data for 2000 attributed 10.7% of incident cases 
globally to children aged 0-14 years.vii In the same analysis in South Africa, 16.1% of 
TB was estimated to have occurred in children younger than 15 years old, with a 
case rate of 501 per 100 000 population in this age group.vii Seventy-five per cent of 
all childhood TB cases globally were recorded for high TB-burden countries, with an 
increase in childhood TB cases noted in many regions of the world, including 
America and Europe.vii   
In a study that reviewed TB notifications over a 10-year period (1985-1994) in two 
urban communities in Cape Town in 1998 (high TB burden and antenatal HIV 
prevalence 0.37% in 1991), among all childhood cases the proportion occurring in 
children aged 0-4 years ranged from 25 to 49% and from 7-12% in those in the 5-14 
year age group (n=1 744) in that period.viii The TB case notification rate among 
children aged 0-5 years was 3.5 times that in adults, highlighting the high burden of 
childhood TB in that setting.viii Although this study might have only been 
representative of similar urban settings, it nonetheless served as an early indicator of 
the burden of childhood TB in high TB-burden settings in South Africa. The limitation 
of this study was that it was confined to two peri-urban communities in Cape Town at 
the beginning of the HIV epidemic, and therefore the findings cannot be extrapolated 
to the general South African context.  
Childhood TB case notifications in South Africa have declined slightly from 63 151 
cases in 2008 to 53 331 in 2012. This mirrors somewhat the decrease in TB case-
finding for cases older than 20 years, which decreased from 305 495 cases in 2008 
to 296 263 cases in 2012. The proportion of cases under 20 years commenced on 
treatment showed a slight decline, from 17.1% of total cases in 2008 to 15.3% of all 
cases in 2012 (Table 4). The proportion of cases by age group varied widely at the 
district level, which may be due to different population age structures and the 
completeness of case-finding, among other factors (Figure 6).  
  
 
Table 4: Number and percentage of TB cases by age group, 2008-2012 
 2008 2009 2010 2011 2012 
AGE 
(group) 
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4.1 Basis for diagnosis: 
The challenges faced by clinicians in determining a definitive diagnosis of TB in 
young children are well described in the literature, and most persist to this 
day.vii,ix,x,xi,xii,xiii,xiv This is mainly due to the difficulties in obtaining sputum samples, 
the paucibacillary nature of disease in young children, the lack of a standard case 
definition, and the difficulties of interpreting radiological features that is pivotal for 
diagnosis in the absence of bacteriological confirmation. This is further complicated 
by “the increased presence of extra-pulmonary disease in young children [and] the 
lower public health priority previously given to childhood TB”.ii,vii 
Bacteriological coverage rates (percentage of cases of PTB for which sputum 
microscopy results were available) improved with each age group, as expected, but 
all age groups showed increases between 2008 and 2012 (Figure 7), suggesting an 
overall increase in cases with microscopy results. However, bacteriological coverage 
remained very low in the age group 5-9 years (24.3% in 2012) even though these 
children should be able to provide sputum samples with encouragement.xv   





4.2 Site of Disease: 
Although pulmonary disease comprises the bulk of TB cases, children, particularly in 
the 10-19 year age groups, experience a substantial proportion of extrapulmonary 
disease. 
Data from the ETR.net show that extrapulmonary TB (EPTB) cases make up 
between 3.9% and 14.5% of all cases aged 0-19 years, with the proportion of EPTB 
cases highest in the 10-14 year age group (Figure 8).  
Figure 8: Percentage of TB cases that are EPTB by age group, 2008-2012 
 
A study in India reported EPTB in 15-20% of HIV-negative cases and 20-70% of 
HIV-positive cases, while in a Thailand study, 40% of HIV-infected patients had 
EPTB.xvi,xvii The data in Figure 9 indicate higher proportions of EPTB in HIV-positive 
children, as has been observed in adults. The largest difference in proportions 
between the HIV-positive and HIV-negative EPTB cases was in the 15-19 year age 
group (16.6% of TB cases are EPTB in those known to be HIV-positive, compared to 
9.4% with EPTB in those with known HIV-negative status).   
 
Figure 9: Percentage of TB cases that are classified as EPTB by age group and HIV 
status, 2012 
 
5 Treatment outcomes 
Outcome data among children and adolescents aged 0-19 years were analysed and 
are presented in this section. Outcome data for the years 2008-2010 were not 
included due to quality concerns described in the case-finding section, while data for 
2012 were incomplete at the time of this analysis. 
Treatment outcome definitions in children and adolescents with TB are reported in 
the same categories applied to adult cases, and are generally defined as follows 
(based on revised WHO definitions):xviii 
Cured  A pulmonary TB patient with bacteriologically confirmed 
tuberculosis at the beginning of treatment and who was 
smear- or culture-negative in the last month of treatment 
and on at least one previous occasion 
Treatment completed  A TB patient who completed treatment without evidence 
of failure BUT there is no record to show that sputum 
smear or culture results in the last month of treatment 
and on at least one previous occasion were negative, 
either because they were not done or because results 
were not available. 
Treatment failed A TB patient whose sputum smear or culture is positive at 
month 5 or later during treatment.  
Died A TB patient who dies for any reason before starting or 
during the course of treatment. 
Lost to follow-up A TB patient who did not start treatment or whose 
treatment was interrupted for two consecutive months or 
more. (This was previously called default. The term 
default is used in this chapter.) 
Not evaluated A TB patient for whom no treatment outcome is assigned. 
This includes cases „transferred out‟ to another treatment 
unit and where the treatment outcome is unknown to the 
reporting unit. Patients who were transferred out are 
recorded as a separate category in the system-generated 
outcomes from ETR.net and are therefore reported in this 
chapter. 
 
5.1 National profile 
Outcome data were available for 62 454 children and adolescents aged 0-19 years 
in 2011. Of these, 69.9% completed treatment, 15.3% were cured, 5.1% defaulted, 
2.25% died on treatment, 0.5% experienced treatment failure, and 7.0% were 
transferred out or not evaluated. Analysis of outcomes by age categories showed 
successful outcomes (cure and treatment completion) reaching 80% in all the age 
groups (86.6% – 0-4 year, 88.0% – 5-9 years, 85.2% – 10-14 years and 80.0% – 15-
19 years). Figure 10 shows treatment outcomes by age group in 2011. 




The proportion of defaulters was relatively similar in the 0-4, 5-9 and 10-14 year age 
groups, with the greatest percentage observed in older adolescents (15-19 years, 
8.2%), a value twice that in the 10-14 year age group (4.1%). Similarly, older 
adolescents also had the largest mortality and failure treatment percentages (3.2% 
and 1.3% in 15-19 years respectively). Overall, mortality was generally low in all the 
age groups, ranging from 1.6% in the 0-4 year age group, 1.7% in those aged 5-9 
years, 2.9% in those aged 10-14 years, and 3.2% in the 15-19 year age group. 
Tuberculosis is generally severe in the youngest children with poorly developed 
immune systems,xix hence a greater proportion of mortality would be expected in the 
0-4 year age group. However, in this analysis, mortality in the 15-19 year age group 
was significantly greater than that seen in children aged 0-4 years (p<0.001). This 
could be due to HIV-associated mortality, a poorer prognosis associated with poor 
adherence to treatment among adolescents, or other causes of mortality in 
adolescents who are on treatment for tuberculosis.xx,xxi,xxii,xxiii  
Various analyses have shown high levels of injury- and trauma-related mortality in 
young people. Studies have also shown that adolescents struggle to adhere to 
chronic medication due to various factors attributed to and associated with the period 
of adolescence.xxiv,xxv However, a more detailed analysis taking into account a range 
of clinical, social and other factors is required to fully explain this observation.  
In all the age groups, more than 6% of cases were either transferred out or not 
evaluated. HIV-associated mortality was high in all age groups, with the highest 
proportion (7.3%) being in the 15-19 year age group (Figure 11). Mortality 
percentages among those aged 0-4 and 5-9 years were similar (1.6% and 1.7 % 
respectively) but higher in children aged 5-9 years who generally have a lower risk 
and burden of TB.xix Although massive strides have been made with regard 
prevention of mother-to-child transmission (PMTCT) of HIV and antiretroviral 
treatment provision in general in South Africa, this high proportion of mortality could 
be partially attributed to the impact of HIV infection, as illustrated by the substantially 
higher death rates in cases known to be HIV-positive (Figure 11). Outcomes did not 
differ much by gender (Figure 12). 
Figure 11: Mortality outcomes in children by age group and HIV status, 2011 
 
 
Figure 12: Treatment outcomes by gender in children and adolescents in South 
Africa, 2011 
 
5.2 Treatment outcome by facility type 
Figure 13 shows that across the country, childhood TB is successfully managed at a 
primary care level, with the majority of children completing treatment or achieving 
cure. Poor outcomes (default, death and failure of treatment) occurred across all 
types of health facilities in all age categories in 2011. However, hospitals had higher 
levels of default and mortality. Higher levels of mortality would be expected from 
hospitals, since the sicker patients and more complicated cases with a greater 
likelihood of mortality are seen there. With regard to default, patients may fail to 
return to hospital because of difficulties in accessing the hospital, especially in rural 
areas where the hospital may be a long distance from where patients live and they 
might have rare or no means of transportation. It is also possible that as a result of 
access problems, some patients may choose to continue treatment at their local 
clinic and be erroneously classified as defaulters. Notable also is the high level of 
transfers out from private care, which most likely reflects transfer to the public health 
sector where TB treatment is provided free of charge. Treatment failure cases were 
mainly recorded in specialised TB hospitals and were most frequent in the 10-14 and 
15-19 year age groups.  
Figure 13: Treatment outcomes in children by age group and facility type (number 
and percentage of cases), 2011 
 
 
5.3 Treatment outcomes by province 
Figure 14 shows treatment outcomes for the children and adolescents across the 
nine provinces in South Africa. The percentage achieving successful treatment 
outcomes (cure and treatment completion) in all age categories 0-4, 5-9, 10-14 and 
15-19 ranged from 63.1% (age group 0-4 years in LP) to above 93% (age group 5-9 
years in GP). However, across all provinces, there is a concerning proportion of 
young patients who did not complete treatment (defaulted), albeit largely confined to 
older adolescents aged 15-19 years (8.2% defaulter rate). The possible reasons for 
this observation have been discussed earlier. Default from treatment is a problem in 
many TB programmes across all age groups. Given the long duration of treatment 
(at least six months), the drug side-effects and the fact that people feel better long 
before they complete the recommended course of treatment, many patients stop 
taking their medication prematurely. However, these patients require a longer course 
of treatment when they eventually return to care, and are at risk of mortality without 
adequate treatment.
xxvi,xxvii Therefore, greater efforts and innovative methods are 
needed to encourage adherence to and completion of treatment among TB patients. 
The highest defaulter rate overall was in North West Province (6.6% in children 0-19 
years). The Eastern Cape and Northern Cape Provinces also had high defaulter 
rates. 
 
Figure 14: Treatment outcomes in children by age group and by province, 2011 
 
Mortality per province is shown in Figure 15 for each age group. Limpopo Province 
(LP) had the highest mortality, followed by Free State, while the WC and GP had the 
lowest mortality rates. The WC in particular has extremely low mortality in all age 
groups. While provinces vary greatly in socio-demographic, economic, disease-
burden profiles and other factors, there is need to investigate how successful 
practices in GP and WC could be adapted and replicated in other provinces with 
higher mortality rates. Mortality was greater in the 10-14 year and 15-19 year age 
groups, as described for the national profile. 
Figure 15: Mortality outcomes in children by age group and by province, 2011 
 
All provinces recorded a proportion of children and adolescents who experienced 
treatment failure (Figure 16). The cases were concentrated in older adolescents: 
1.3% in the age group 15-19 years recorded treatment failure. Mpumalanga Province 
recorded the highest failure rates of 2.2% in the 10-14 year age group, 2.0% in the 
15-19 age group  and 1.2% overall (age 0-19 years). Although the overall proportion 
is low, these data are concerning, given the increasing burden of drug-resistant 
tuberculosis in South Africa.  
Figure 16: Treatment failure in children by age group and by province, 2011 
 
5.4 Treatment outcomes by district 
The proportion of children and adolescents achieving successful treatment ranged 
from a low of 61.3% in Capricorn (LP) to a high of 93.1% in Ekurhuleni (GP). In 30 
districts, treatment success rates were ≥85% overall among children and 
adolescents. Default was highest in Waterberg (LP) at 10%, followed by Pixley ka 
Seme (NC) at 9.7% and then by Buffalo City and OR Tambo Districts (EC) with 8.7 
and 8.2% default respectively. The mortality rate at district level ranged from 0.4% in 
Overberg (WC) to 7.2% Mopani (LP). Waterberg (LP) had the second-highest 
mortality rate at 6.4%. Other districts with high mortality rates in 2011 were Frances 
Baard (NC) with 5.6%, and T Mofutsanyana (FS) and Bojanala (NW) each reporting 
4.9% mortality in the 0-19 year age group in 2011. Treatment failure was above 1% 
in 13 districts, with the highest proportions reported in Central Karoo (WC) at 1.8% 
and JT Gaetsewe (NC) with 1.7%. 
Figure 17: Treatment outcomes in children by age group, by district, 2011 
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This narrative presents important information on TB in children and adolescents in 
South Africa, and highlights the challenges of TB data management and its impact 
on reporting. As expected, the burden of childhood TB is high, with a large proportion 
concentrated in the 0-4 year and 15-19 year age groups. With momentum and focus 
on HIV counselling and testing (HCT) and a move towards integration of TB and HIV 
care, cases with unknown HIV status dropped significantly between 2008 and 2012. 
However, the proportion remains high, indicating a need for further effort to increase 
testing and recording of HIV status in all TB cases.   
TB in children and adolescents accounted for 15.3% to 17.1% of all TB cases 
between 2008 and 2010. This is within the expected proportion for high TB burden 
countries. Given that the expected estimates are based on children aged 0-14 years, 
the cases recorded on ETR.net may be underestimating the total disease burden in 
this age group. This is supported by the fact that in very young children, TB can 
easily be misdiagnosed as being other respiratory tract infections, hence some 
cases may be undiagnosed. The same could apply to older adolescents, especially 
males, who may not readily present to healthcare facilities even when symptomatic. 
These concerns extend to drug-resistant TB, which also tends to be undiagnosed 
and poorly quantified in children.xxviii 
Treatment outcomes present an encouraging picture, indicating successful treatment 
in the majority of cases. However, the proportion of defaulters, even though small, 
needs to be addressed given the negative consequences of defaulting from 
treatment. As expected, mortality was high among HIV-infected cases, with the 
highest proportion in those aged 15-19 years. Early initiation of ART has been shown 
to reduce mortality in HIV-infected patients and is thus recommended as soon as 
possible for HIV-infected children (0-14) and adults, regardless of CD4 count.xxix 
Implementation of this guideline should be assessed in all facilities. 
The provincial and district outcome profiles vary due to many factors. In many areas, 
outcomes are favourable, requiring a small proportion of unfavourable outcomes to 
be addressed. In other areas, more work is needed to reduce concerning burdens of 
default from treatment and mortality in children and adolescents.  
Finally, this narrative serves as a useful review in the journey towards achieving the 
goals of reducing the burden of TB in children and adolescents in South Africa. 
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Abstract 
Background: 
Tuberculosis (TB) in children, particularly in those under five years is regarded as 
an indicator of there being an infectious pool in the community. The World Health 
Organization (WHO) has focused on childhood tuberculosis, recognizing its 
contribution to the overall TB burden and to child survival. The “Roadmap for 
Childhood Tuberculosis” identifies the need to know the incidence of childhood TB 
in order to design and implement specific public health interventions to limit the 
spread of the disease and orientate health services in early TB detection, treatment 
and retention in care to prevent unnecessary morbidity and mortality. 
Purpose: 
The purpose of this research is to investigate the epidemiology of childhood TB in 
South Africa from 2008-2012 using data recorded in the Electronic TB Register, in 
order to inform TB control policy and practice. 
Objectives 
The objectives of this study are: 
a. To describe TB incidence trends by age, sex and other demographic variables;  
b. To document the characteristics of childhood TB; 
c. To determine the proportion of childhood  TB; and 
d. To compare the proportion of childhood TB cases in South Africa to the WHO 
estimated proportions for childhood TB cases in high burden countries. 
An observational analytical cross-sectional study design will be used.  Data from 
the Electronic TB register (ETR.Net) will be summarised and comparisons made to 
the expected WHO estimates. The study population will be all children registered 
with B on the ETR.Net in South Africa from 2008 to 2012. 
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1 Introduction  
The World Health Organization (WHO) declared tuberculosis a global emergency 
in 1993, with South Africa being one of 22 high burden countries.1 In 2012, South 
Africa had a TB incidence of 1003 per 100 000 placing it amongst the highest in 
the world.2 
The WHO defines childhood tuberculosis as that tuberculosis affecting those under 
the age of 15 years. The South African Children’s Act 38 of 2005 defines a child as 
being less than 18 years of age. In this study a child would be under 15 years of 
age.  
Childhood TB particularly in those under five years is  an indicator of there being 
an infectious pool of TB in the community.3 In the past, the WHO did not 
emphasize childhood TB as more than 95% of children are smear negative and 
therefore are not part of the infectious pool.4 This mindset has changed in recent 
years with WHO reporting in 2013 that globally there were an estimated 530 000  
children with TB, with more than 200 children dying of TB every day.5   
 Few countries report the incidence of childhood TB as data is seldom available. 
The diagnosis of childhood TB is difficult and is rarely supported by laboratory 
confirmation.6  In 2000, South Africa reported an incidence of childhood TB of 501 
per 100 000 population  from birth to14 years.5 
This study will use data of all children registered with TB on the ETR.Net in South 
Africa from 2008 to 2012 in an attempt to describe the epidemiology of childhood 
tuberculosis in South Africa and assess whether demographic factors influence TB 
outcomes. 
The findings of this study can assist the Department of Health to implement 
targeted TB interventions appropriate for children and design a range of health 
interventions focussed on prevention, early detection and treatment in order to 
decrease the burden of childhood TB specifically. 
 
2 Literature Review  
2.1 Introduction  
The focus on childhood TB has gained momentum in recent years. There is greater 
awareness that the increased incidence of childhood tuberculosis in a community 
is a reflection of the bigger burden of tuberculosis in adults in the same community. 
The study will describe the demographic profile of childhood TB in South Africa, 
looking at trends in sites of disease and diagnostic methods most commonly used. 
It will also compare the proportion of cases in South Africa to the WHO estimated 
proportions expected in a high TB burden countries. The study will also describe 
the outcomes for childhood TB over the last 5 years and determine if there are any 
associations between clinical outcomes and other demographic factors such as 
age, gender, HIV status and severity of the disease. 
2.2 Burden of Tuberculosis  
According to the WHO, TB remains the second leading cause of death in the world 
and substantially affects the health of millions of people. Globally, there were 8.6 
million people who developed TB in 2012. Of these 530 000 were less than 15 
years of age. The African Region accounts for 28% (estimated 2.3 million cases) of 
the global TB burden with an estimated prevalence of 303 per 100 000 (95% 
Confidence Interval (CI): 239 to 373) in 2012.  South Africa had an estimated 450 
000 cases (95% CI 160 000 to 880 000) and an estimated prevalence of 857 per 
100 000 (95%CI 305 to 1680) in 2012.7 The prevalence of TB is not routinely 
measured due to the requirement of large cohorts and the expense involved.  
The notification system is considered a satisfactory proxy indicator for incidence of 
TB. The World Health Organisation’s estimates the incidence of TB in South Africa 
is 530 000 (95% CI 430 000 to 630 000) cases in 2012. The  incidence risk of 1000 
per 100 000 population (CI 827 to 1190) is the highest incidence amongst the high 
burden countries.7  
2.3 Demographic Profile of Childhood Tuberculosis 
Very few studies have been published on demographic profiles of children with TB. 
The Nairobi Urban Health and Demographic Surveillance System, situated in two 
slum areas in Nairobi, Kenya, reported that AIDS and TB were ranked sixth on the 
list of premature mortality among children under the age of five years (609 year of 
Life Lost (YLL) out of 15129 YLL for under five mortality), but was the leading 
cause of death in those aged 5 years and above. This data did not consider the 
age categories used by the WHO as it divided the data into two age categories, 
zero to four years and those above 5 years, therefore it is not possible to determine 
the burden on children aged between 5 and 14 years.8 
2.4 WHO Estimated Proportions for Childhood Tuberculosis 
The WHO estimates that in high burden settings, it is expected that childhood TB 
cases will comprise 10 to 20% of the total TB caseload.5 Globally childhood TB is 
on the increase in many countries although 75% of childhood TB cases notified in 
2000 were from high burden countries.6 In the same year, (2000) Botswana 
reported increases in cases as well as a proportion of 12% of all Tuberculosis 
cases being under the age of 15 years, as was the case in Malawi in 1998.6  
In a study by Rie et al, carried out in two urban communities in Cape Town in 1998, 
it was found that the 0 to 5 year age group comprised 25 to 49% of the total 
number of childhood TB cases (n=3588), and the 5 to14 year age group comprised 
7 to 12% of the total cases (n=1744) in that period. The limitation of this study was 
that it was confined to two peri-urban communities in Cape Town and therefore the 
data cannot be extrapolated to the general South African context. 
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3 Purpose of the Study 
The purpose of this research is to investigate the epidemiology of childhood TB in 
South Africa from 2008-2012 using data recorded in the Electronic TB Register, in 
order to inform TB control policy and practice. 
4 Specific Objectives 
The objectives of this study are: 
a. To describe TB incidence trends by age, sex and other demographic variables;  
b. To show the characteristics of childhood TB; 
c. To determine the proportion of childhood  TB; and 
d. To compare the proportion of childhood TB cases in South Africa to the WHO 
estimated proportions for childhood TB cases in high burden countries. 
5 Type of Research 
Epidemiological research, which will be applied at a public health level, in order to 




Cases identified as TB by means of bacteriological, radiological or clinical 
findings.  
b. Electronic Tuberculosis Register (ETR.Net) 
The ETR.Net ETR.Net is an electronic tuberculosis register used in South Africa, 
designed for TB/HIV surveillance, program monitoring and evaluation 
c. Childhood TB 
Persons diagnosed with TB by means of bacteriological, radiological or clinical 
findings that are 0 to 14 years of age 
d. TB Outcomes 
The health outcome of the patient at the end of the treatment as defined by the 
National Tuberculosis Management Guidelines 2009.  
Cure: Patient who is smear-negative in the last month of treatment and on 
at least one previous occasion at least 30 days prior. 
Treatment completed: Patient who has completed treatment but who does 
not meet the criteria to be classified as cure or treatment failure. 
Treatment success: Patient who is cured or treatment completed 
Treatment failure: Smear positive patient who remains or is again smear-
positive at 5 months (for new) or 7 months (for retreatment) after treatment 
start date or whose DST shows MDR-TB at 2 or 3 months. 
Died: Patient who dies for any reason during the course of TB treatment. 
Treatment default: Patient whose treatment was interrupted for more than 
two consecutive months 
Transfer out: Patient who has been transferred to another reporting unit 
(e.g. district) and for whom the treatment outcome is not known.9 
e. Childhood TB Incidence Risk 
The proportion of children aged 0 to 14 who developed TB during the specified 
time period, reported for the age groups 0 to 4 years, 5 to 9 years and 10 to 14 
years against the district, provincial and national estimated populations for 
those age groups according to the 2011 census. 
f. Drug Resistant TB 
TB caused by strains of Mycobacterium tuberculosis that are resistant to 
isoniazid and and/or rifampicin 
7 Research Methods 
7.1 Study Setting 
This study will take place using the Electronic TB Register from all nine provinces 
of South Africa 
7.2 Study Design 
An observational analytical cross sectional study design will be used.   
7.3 Target Population.  
The results of this study will be generalizable to the children aged 0-14 in South 
Africa as well those in other lower to middle income countries in Africa with a 
similar demographic and disease (HIV) profile. 
7.4 Study Population 
The study population will be all children registered with Tuberculosis, and 
diagnosed by means of bacteriological, radiological or clinical findings and 
recorded in the ETR.Net in South Africa from 2008 to 2012. 
7.4.1 Inclusion / Exclusion Criteria 
Inclusion Criteria: 
 All children in the age groups 0 to 4, 5 to 9, and 10 to14 years registered on TB 
treatment in the ETR.Net with drug sensitive TB between 2008 and 2012, 
irrespective of the diagnostic method or the site of the disease.  
Exclusion Criteria: 
 TB patients 15 years and older 
 Children aged 0 to 14 years with drug resistant TB 
7.5 Study Sample 
7.5.1 Method of selecting sample 
A census will be used of all records of TB patients aged 0 to14 during 2008 to 2012 
7.5.2 Size of sample 
The ETR.Net data-base contains 235 836 records of children aged 0 to 14 fitting 
the inclusion criteria for this study.  
7.6 Data Sources 
The Electronic TB Register (ETR.Net) will be the source of the data. Records from 
1 January 2008 to 31 December 2012 will be used. The ETR.Net is the software 
used by the South African National Department of Health to capture routine patient 
level data for drug sensitive TB in all public health facilities  
7.6.1 Measurement instruments and data collection techniques 
The data is available in a Structured Query Language (SQL) database which is 
exported into MS Excel and will be imported into a statistical software package 
(STATA13) for processing and analysis. 
7.7 Measures to Ensure Validity 
7.7.1 Internal validity 
7.7.1.1 Selection bias 
Selection bias will be minimized by the identification of duplicate records and the 
fact that all records will be used. The database has incomplete records for certain 
reporting units and for some reporting periods. This will have to be noted in detail 
and analysis controlled to minimize the effect on the results 
7.7.1.2 Information bias 
Information bias will be minimized by automatic importing of the information from 
the electronic TB database into the analysis software thereby minimizing human 
capture error. It is acknowledged that there is potential for information bias with any 
clinician recorded data. The database has incomplete records for certain reporting 
units and for some reporting periods. This will have to be taken into account during 
analysis. These incomplete records may result in skewed results for those periods 
or reporting units. 
7.7.2 External validity / generalizability 
This study examines all cases over the study period and results will be available at 
a provincial and district level, therefore the results of this study will be 
generalizable to the TB population under 15 years in every district. The results may 
also be generalizable to other countries with a similar HIV and AIDS and TB 
burden. 
  
7.8 List of Variables  
Variable Possible Associations 
Sex  Nil  
Age Clinical Outcomes 
HIV status 
Site of TB Clinical Outcomes 
HIV status 
Diagnostic methods Age  
HIV status Clinical Outcomes 
Age 
Geographic location Diagnostic methods 
Outcomes Age, diagnostic methods, 
HIV status, site of disease 
 
7.9 Plan for Data Handling/Processing 
7.9.1 Data Collection 
Data from the national ETR.Net data set will be used for the study. The data that 
will be analyzed is aggregated to the 52 districts level and therefore contains no 
patient identifiers, thereby protecting the confidentiality of the TB patient.  
7.9.2 Data storage  
1. Copies of all data files will be kept on an external hard drives and locked in a safe 
in a separate location. A further back up will be stored in an encrypted file on an 
external server. 
2. Computers and files will be password protected with access limited to the 
researcher. 
7.9.3 Back up of data 
Data will be backed up as follows: 
 Daily – The most recent backup will be kept off-site 
 Weekly backups will be kept for a month 
 Monthly backups will be kept for 6 months 
 Quarterly backups will be kept for one year 
 6 monthly back-ups  
7.10 Statistical Methods 
7.10.1 Descriptive statistics 
Descriptive methods will be used to analyze data. Modes, medians and ranges will 
be measured for a variety of categorical variables. Comparisons will be made 
between proportions of childhood TB in South Africa and the proportions estimated 
by WHO for high burden countries. 
7.10.2 Analytic statistics 
Appropriate Measures of association will be determined between clinical outcomes 
and demographic variables 
7.11 Study Limitations 
 This study will use routine data and therefore patients that are not registered but 
that may be on treatment will not be included e.g. those being treated in the private 
sector. 
 The study will be limited by the quality of the routine records used. Where data is 
found to be missing, the patient’s individual record will be used to complete the 
missing data where possible.    
8 Ethical Considerations 
8.1.1  Institutional Ethical Review Board 
Application for expedited ethical approval will be made to the Biomedical Research 
Ethics Committee at University of KwaZulu-Natal. 
8.1.2  Permissions 
Permission has been sought for the use of this data from the National Department 
of Health who are custodians of the data. This will only be granted once approval 
has been granted by BREC. The project will be registered for academic purposes 
with the School of Nursing and Public Health, Research Higher Degrees 
Committee. 
8.1.3 Informed Consent and Participant Information  
A waiver of written informed consent to access and use routine ETR data is 
requested.  This study uses retrospective, routinely collected information.  The 
number of records included is large, with an estimated 235 836 patients included.  
For these reasons, it is not feasible to get patient consent. No identifying patient 
information will be used in the analysis.   
  
9 Work Plan 
9.1  Budget  
Master of Public Health: Dissertation 
February 2014 - April 2015 
Categories Item 






            
Personnel         
  Student researcher FTE   N/A 0 
TOTAL PERSONNEL COST       0 
            
Travel & Transportation         
  Meetings with Supervisor (face to face) trips 10 400 4 000.00 
TOTAL OF TRAVEL & 
TRANSPORTATION 
      4 000.00 
            
Equipment         
  Use of personal laptop unit   N/A 0 
TOTAL OF EQUIPMENT       0 
            
Materials         
  Stationery unit 1 300 300 
TOTAL OF MATERIALS       300 
            





10 400 4 000.00 
  Data Management (use of HST staff) 
per 
hour 
40 N/A 0 
  Professional editing 
per 
hour 
5 200 1 000.00 
TOTAL OF OTHER COSTS       5 000.00 
            
TOTAL BUDGETED EXPENSES       9 300.00 
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